Breadcrumb

Business Development Office

The Business Development Office (BDO) at the Research Institute of the McGill University Health Centre (RI-MUHC) assists researchers in finding funding opportunities, preparing grant proposals, identifying and pursuing commercialization opportunities, and creating partnerships.

Business development services

Services offered by the Business Development Office (BDO) include:

Funding opportunities

  • We maintain a database of current funding opportunities
  • We match research teams with grant opportunities aligned with their science
  • We assist with leveraging and obtaining matching funds
  • We initiate, structure and support large team grants

Preparation of grant proposals

  • We provide grant writing support, including conducting scientific review and establishing project management structure for applications
  • We develop and review budgets
  • We liaise with funding agencies
  • We prepare institutional letters of support

Business development and commercialization

  • We identify market opportunities for novel technologies
  • We facilitate technology transfer and the creation of start-up companies
  • We conduct competitive benchmarking analyses
  • We work with researchers to acquire proof-of-concept funds

Creating partnerships

  • We secure funding through partnerships with industry, government and non-profits
  • We maintain relationships with hospital foundations and other non-traditional funding agencies

Success stories

These are just a few examples of recent successes in business development at the RI-MUHC.

Precision screening tool for early diagnosis of ovarian and endometrial cancers developed through innovative partnerships

Precision screening tool for early diagnosis of ovarian and endometrial cancers developed through innovative partnerships
Together, ovarian and endometrial cancers represent the fourth leading cause of cancer-related deaths among Canadian women. Although more than 80% of these patients can be cured if their cancer is detected early, most women are only diagnosed after the cancer...

Bringing an innovative retinal gene therapy to clinic

Bringing an innovative retinal gene therapy to clinic
Imagine a world devoid of colour, a world where the smile of a loved one is indistinguishable from a black abyss. This world is the everyday reality for people suffering from Zellweger spectrum disorder (ZSD). Affecting around 2,000 people worldwide...

New target for cystic fibrosis drug development: Ceramides

New target for cystic fibrosis drug development: Ceramides
Cystic fibrosis (CF) is a deadly respiratory disease characterized by thick mucus in the lungs. This mucus becomes colonized by pathogens and initiates a vicious cycle of infection and inflammation. Although no effective therapeutic options for CF exist...

Contact us

We welcome inquiries about Business Development Office services. Please email us: Marlies.otter@affiliate.mcgill.ca

Explore research at the RI-MUHC